Serum concentrations of free fatty-acid (FFA) have been shown to be raised in patients with acute myocardial infarction by Kurien and Oliver (I966) . In a more detailed study the same authors (Oliver, Kurien, and Greenwood, I968) found a positive relation between serum FFA levels and complicating arrhythmias and death after myocardial infarction. They postulated that the rise of serum FFA was a consequence of mobilization of FFA from adipose tissue, induced by noradrenaline. In other studies, the level of catecholamines in the urine was shown to be raised in cases of acute myocardial infarction complicated by arrhythmias and/or cardiogenic shock (Jewitt et al., i969) , and plasma noradrenaline concentration was raised after myocardial infarction and related -directly or indirectly -to the development of serious arrhythmias (McDonald et al., I969) . It follows that both these latter studies support the theory that the rise in the plasma FFA concentration in cases with myocardial infarction could be secondary to catecholamineinduced fatty acid mobilization from adipose tissue.
During the lipolysis of triglycerides in adipose tissue, glycerol is formed in addition to free fatty acids and is released to plasma. In contrast to free fatty acids, glycerol cannot be reused in adipose tissue or muscle (Steinberg, I964; Havel, I965) and therefore is a better index of the rate of adipose tissue lipolysis than the plasma FFA.
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The present study was started in order to elucidate (i) whether a relation existed between plasma glycerol concentration and complicating arrhythmias during acute myocardial infarction, and (2) whether determination of plasma glycerol concentration could be used for selecting cases with myocardial infarction prone to get complicating arrhythmias. Rutenberg, Pamintuan, and Soloff (I969) found no relation between the initial level of serum FFA and the future development ofcomplications, but, as stated above, the plasma glycerol might be a more discriminative parameter than FFA.
There is some evidence in favour of the theory that the arrhythmias during acute myocardial infarction are due to a direct deleterious effect of free fatty acids on the injured myocardium (Kurien, (Nelson, I970) . However, whether this theory is correct or not, the plasma glycerol theoretically could be of value as a predicting index and was therefore judged as worth testing.
Subjects
The material consisted of I84 patients who were admitted to hospital with acute chest pain. Patients with diabetes mellitus and patients given theophyllamine and/or sympathomimetic drugs were excluded. None of the patients showed any clinical signs of failure or shock when the samples were taken.
The study was divided into two separate series. In series A capillary blood was used and the samples had to be taken at fixed times during the day, e.g. at 9 a.m., noon, and 3 p.m. The patients in both the series were looked after under the same conditions in the coronary care unit of the hospital.
In series B the venous blood samples were taken immediately on admission to hospital.
In series A the first blood samples were taken 2-I8 hours after the onset of symptoms whereas blood samples in series B were taken 2-7 hours after onset. The mean time elapsed between onset of symptoms and taking of samples was about the same in the different groups in respective series.
Diagnostic criteria The diagnosis of myocardial infarction was based on electrocardiographic evidence, using'the criteria recommended by WHO, and significantly raised serum levels of aspartate aminotransferase (SGOT). Arrhythmias were displayed on bedside oscilloscopes with intermittent direct recordings. Arrhythmias were considered to be present if there were more than 6 ventricular extrasystoles a minute or more serious disturbances of heart rhythm (atrial flutter or fibrillation, ventricular fibrillation).
In series A patients were divided retrospectively into four different groups according to their diagnosis (Table i) . These groups and the age and sex of the patients are shown in Table i .
Patients with previous infarctions and/or previous histories of angina were classified in group II. In these patients the suspicion of myocardial infarction could not be verified with electrocardiograms or SGOT levels. Group I consisted of subjects with chest pain of non cardiac origin.
In series B, the same classification was used, except that the patients with previous infarction and/or angina were separated into two groups (II and III), depending on the absence or the presence of arrhythmias. Thus, the patients in series B were divided into five groups. Details of these patients are summarized in Table 2 .
Methods
The determination of plasma FFA was made according to Laurell and Tibbling (I967) . Plasma glycerol concentration was determined according to the method described by the same authors (Laurell and Tibbling, I966). The statistical evaluation was made using Wilcoxon's rank sum test (Wilcoxon, I945) .
Results
Plasma FFA and glycerol values of the four groups of patients in series A are shown in Fig. i and 2 . The mean glycerol value of the patients in group IV was significantly higher than those of groups II and III (Table 3) . No significant differences between the mean FFA values of the groups were found. The differences between the groups are summarized in Table 4 . In Fig. 5 plasma FFA values of all the patients in series B are plotted against plasma glycerol values. There was a highly significant correlation between plasma FFA and glycerol concentrations (P < o-ooi), but the glycerol concentration was clearly the more sensitive parameter of the two. Similar results were obtained when plotting plasma FFA/glycerol data from series A.
Some of the patients with myocardial infarction complicated by arrhythmias died during their stay in hospital, but their glycerol levels did not differ significantly from the other patients' in their respective groups. Any differences between the men and women were not found in any of the groups as regards plasma FFA and glycerol. FIG. 3 The individual plasma FFA concentrations of the patients in the 5 groups in series B. For an explanation of the diagnostic groups I-V, see Table 2 . The mean concentration of the groups is indicated by horizontal lines. 
